582 Companies
PhaseBio Pharmaceuticals is a clinical-stage biopharmaceutical company that is focused on finding novel therapies for cardiovascular and cardiopulmonary diseases. Its pipeline includes bentracimab,...
PhaseBio Pharmaceuticals, Inc. Annual Report 2020Lexington-based biotech firm, Frequency Therapeutics, Inc. is leveraging its innovative Progenitor Cell Activation approach to develop cutting-edge therapeutics that can help activate the body's na...
Frequency Therapeutics, Inc. Annual Report 2021GlycoMimetics, a clinical-stage biotech firm, is making strides in the field of glycobiology-based therapies for cancers and inflammatory diseases in the United States. Notably, the company is deve...
GlycoMimetics Inc Annual Report 2023Miami-based biopharmaceutical company Veru Inc. has made significant strides in the development of potential treatments for COVID-19, breast cancer, and prostate cancer. The company's product lineu...
Veru Annual Report 2023Biopharmaceutical company, Corbus Pharmaceuticals Holdings, Inc., has been making strides in its mission to combat serious illnesses through product development. The firm is currently working on CR...
Corbus Pharmaceuticals Holdings Annual Report 2023Cambridge, Massachusetts-based biopharmaceutical firm, Merrimack Pharmaceuticals, Inc., has been in operation since 1993. As a player in the industry, the company is primarily involved in the devel...
Merrimack Pharmaceuticals Inc Annual Report 2023CIRCOR International, Inc. is a global leader in the design, manufacturing, and distribution of flow and motion control products, serving customers in Europe, the Middle East, Africa, North America...
Circor International Inc Annual Report 2020Epizyme, Inc. is a clinical stage biopharmaceutical company that focuses on developing epigenetic therapies for cancer patients. The company's product platform creates small molecule inhibitors of ...
Epizyme Inc Annual Report 2020MEI Pharma, Inc., a late-stage pharmaceutical company headquartered in San Diego, CA, has been making steady strides in the development and commercialization of therapies aimed at treating cancer. ...
MEI Pharma, Inc. Annual Report 2023Celyad Oncology SA, a clinical-stage pharmaceutical company, is dedicated to discovering and developing CAR-T cell therapies that target cancer. Their foremost candidates include CYAD-101, an allog...
Celyad SA Annual Report 2023Sinovac Biotech Ltd. is a biopharmaceutical company based in China that specializes in the development and manufacturing of vaccines for human infectious diseases. Its range of vaccines includes pr...
Sinovac Biotech, Ltd. Annual Report 2023Alector, Inc., a clinical stage biopharmaceutical company headquartered in South San Francisco, California, is making strides in developing therapies for the treatment of neurodegeneration diseases...
Alector Annual Report 2023RedHill Biopharma Ltd., a specialty biopharmaceutical company with a focus on gastrointestinal and infectious diseases, boasts an impressive portfolio of drugs including Movantik, Talicia, and Aemc...
RedHill Biopharma Ltd. Annual Report 2023Amarin Corporation plc, a Dublin-based pharmaceutical company focused on the development and commercialization of treatments for cardiovascular diseases, is expanding its reach worldwide. Its flags...
Amarin Corporation Annual Report 2023Biotechnology company Replimune Group, Inc. is utilizing its proprietary Immunotherapy platform to advance oncolytic immuno-gene therapies for the treatment of cancer. The company's lead product ca...
Replimune Group, Inc. Annual Report 2022